Sessa Capital Im, L.P. Bluebird Bio, Inc. Transaction History

Sessa Capital Im, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $3.71 Million - $9.67 Million	-912,328 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $8.27 Million - $15 Million	-922,637 Reduced 50.28%	912,328 $9.11 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $7.14 Million - $13.3 Million	634,965 Added 52.91%	1,834,965 $35.1 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $5.86 Million - $7.18 Million	325,000 Added 37.14%	1,200,000 $38.4 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $14.5 Million - $29.7 Million	875,000 New	875,000 $26.4 Million

149

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $652M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.